:Conclusions: in a cohort of 166 patients from 18 to 85 years hospitalised with COVID-19, hydroxychloroquine treatment with 800mg added loading dose increased survival when patients were admitted in early stages of the disease. '''''There was a non-statistically significant trend towards survival in all groups, which will have to be clarified in subsequent studies.''''' | :Conclusions: in a cohort of 166 patients from 18 to 85 years hospitalised with COVID-19, hydroxychloroquine treatment with 800mg added loading dose increased survival when patients were admitted in early stages of the disease. '''''There was a non-statistically significant trend towards survival in all groups, which will have to be clarified in subsequent studies.''''' |